Literature DB >> 20075198

microRNA, cell cycle, and human breast cancer.

Zuoren Yu1, Renato Baserga, Lide Chen, Chenguang Wang, Michael P Lisanti, Richard G Pestell.   

Abstract

The discovery of microRNAs as a novel class of gene expression regulators has led to a new strategy for disease diagnostics and therapeutics. Cell cycle, cell proliferation, and tumorigenesis are all regulated by microRNAs. Several general principles linking microRNAs and cancer have been recently reviewed; therefore, the current review focuses specifically on the perspective of microRNAs in control of cell cycle, stem cells, and heterotypic signaling, as well as the role of these processes in breast cancer. Altered abundance of cell cycle regulation proteins and aberrant expression of microRNAs frequently coexist in human breast cancers. Altered microRNA expression in breast cancer cell lines is associated with altered cell cycle progression and cell proliferation. Indeed, recent studies have demonstrated a causal role for microRNA in governing breast tumor suppression or collaborative oncogenesis. This review summarizes the current understanding of the role for microRNA in regulating the cell cycle and summarizes the evidence for aberrant microRNA expression in breast cancer. The new evidence for microRNA regulation by annotated genes and the involvement of microRNA in breast cancer metastasis are discussed, as is the potential for microRNA to improve breast cancer diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075198      PMCID: PMC2832125          DOI: 10.2353/ajpath.2010.090664

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  83 in total

1.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells.

Authors:  Yun Lu; J Michael Thomson; Ho Yuen Frank Wong; Scott M Hammond; Brigid L M Hogan
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

2.  miR-21-mediated tumor growth.

Authors:  M-L Si; S Zhu; H Wu; Z Lu; F Wu; Y-Y Mo
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

3.  MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.

Authors:  David C Corney; Andrea Flesken-Nikitin; Andrew K Godwin; Wei Wang; Alexander Yu Nikitin
Journal:  Cancer Res       Date:  2007-09-06       Impact factor: 12.701

4.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

Review 5.  Role of miRNA in carcinogenesis and biomarker selection: a methodological view.

Authors:  Farid E Ahmed
Journal:  Expert Rev Mol Diagn       Date:  2007-09       Impact factor: 5.225

6.  A microRNA component of the p53 tumour suppressor network.

Authors:  Lin He; Xingyue He; Lee P Lim; Elisa de Stanchina; Zhenyu Xuan; Yu Liang; Wen Xue; Lars Zender; Jill Magnus; Dana Ridzon; Aimee L Jackson; Peter S Linsley; Caifu Chen; Scott W Lowe; Michele A Cleary; Gregory J Hannon
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Authors:  Valery Tarasov; Peter Jung; Berlinda Verdoodt; Dmitri Lodygin; Alexey Epanchintsev; Antje Menssen; Gunter Meister; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

8.  Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal.

Authors:  Raphael Rubin; Alla Arzumanyan; Angela Rachele Soliera; Brian Ross; Francesca Peruzzi; Marco Prisco
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

9.  The let-7 microRNA represses cell proliferation pathways in human cells.

Authors:  Charles D Johnson; Aurora Esquela-Kerscher; Giovanni Stefani; Mike Byrom; Kevin Kelnar; Dmitriy Ovcharenko; Mike Wilson; Xiaowei Wang; Jeffrey Shelton; Jaclyn Shingara; Lena Chin; David Brown; Frank J Slack
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

10.  MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.

Authors:  R Garzon; F Pichiorri; T Palumbo; M Visentini; R Aqeilan; A Cimmino; H Wang; H Sun; S Volinia; H Alder; G A Calin; C-G Liu; M Andreeff; C M Croce
Journal:  Oncogene       Date:  2007-01-29       Impact factor: 9.867

View more
  50 in total

1.  Pharmacogenomic Discovery Delineating the Genetic Basis of Drug Response.

Authors:  Wei Zhang; Yinan Zheng; Lifang Hou
Journal:  Curr Genet Med Rep       Date:  2013-09-01

Review 2.  In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

Authors:  Yunching Chen; Dong-Yu Gao; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2014-05-22       Impact factor: 15.470

Review 3.  Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis.

Authors:  John P Lydon; Bert W O'Malley
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

4.  The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags.

Authors:  Bonnie W McLeod; Mark L Hayman; Angela L Purcell; Joshua S Marcus; Erich Veitenheimer
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

5.  miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies.

Authors:  Deug-Chan Lee; Roberto Romero; Jung-Sun Kim; Adi L Tarca; Daniel Montenegro; Beth L Pineles; Ernest Kim; JoonHo Lee; Sun Young Kim; Sorin Draghici; Pooja Mittal; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Pathol       Date:  2011-08       Impact factor: 4.307

6.  Association of microRNA 17-92 cluster host gene (MIR17HG) polymorphisms with breast cancer.

Authors:  Diego Chacon-Cortes; Robert A Smith; Rodney A Lea; Philippa H Youl; Lyn R Griffiths
Journal:  Tumour Biol       Date:  2015-02-14

7.  Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.

Authors:  Ajda Coker-Gurkan; Derya Bulut; Recep Genc; Elif-Damla Arisan; Pınar Obakan-Yerlikaya; Narcin Palavan-Unsal
Journal:  Mol Biol Rep       Date:  2018-11-23       Impact factor: 2.316

8.  Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study.

Authors:  Jeannette T Bensen; Chiu Kit Tse; Sarah J Nyante; Jill S Barnholtz-Sloan; Stephen R Cole; Robert C Millikan
Journal:  Cancer Causes Control       Date:  2013-03-23       Impact factor: 2.506

9.  Complexity in regulation of microRNA machinery components in invasive breast carcinoma.

Authors:  Sun Young Kwon; Jae-ho Lee; Bora Kim; Jong-Wook Park; Taeg Kyu Kwon; Sun Hee Kang; Shin Kim
Journal:  Pathol Oncol Res       Date:  2014-02-27       Impact factor: 3.201

10.  KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.

Authors:  Konstantinos G Sidiropoulos; Qiang Ding; Georgios Pampalakis; Nicole M A White; Peter Boulos; Georgia Sotiropoulou; George M Yousef
Journal:  Mol Oncol       Date:  2016-04-08       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.